subscribeSubscribe
Perrigo`s Opill OTC birth control med teams up with WNBA

Perrigo`s Opill OTC birth control med teams up with WNBA
FIERCE PHARMA
10 Apr 2024
Share Share
Lupin`s Generic Ethinyl Estradiol, Levonorgestrel Receives Approval in the U.S.

Lupin`s Generic Ethinyl Estradiol, Levonorgestrel Receives Approval in the U.S.
FDA
15 Feb 2024
Share Share
Xiromed`s Generic Levonorgestrel and Ethinyl Estradiol Receives Approval in the U.S.

Xiromed`s Generic Levonorgestrel and Ethinyl Estradiol Receives Approval in the U.S.
FDA
16 Aug 2023
Share Share
FDA Approves First Nonprescription Daily Oral Contraceptive

FDA Approves First Nonprescription Daily Oral Contraceptive
FDA
14 Jul 2023
Share Share
Agile Therapeutics Announces the Availability of Twirla® to MMCAP Infuse Members

Agile Therapeutics Announces the Availability of Twirla® to MMCAP Infuse Members
GLOBENEWSWIRE
26 Jun 2023
Share Share
Bayer launches `Seeing Red` campaign to raise awareness for Mirena`s use

Bayer launches `Seeing Red` campaign to raise awareness for Mirena`s use
Nicole DeFeudis ENDPTS
16 May 2023
Share Share
Perrigo`s OTC bid for contraceptive Opill secures May FDA adcomm

Perrigo`s OTC bid for contraceptive Opill secures May FDA adcomm
Kevin Dunleavy FIERCE PHARMA
28 Mar 2023
Share Share
Hetero`s Generic Levonorgestrel, Ethinyl Estradiol Receives Approval in the U.S.

Hetero`s Generic Levonorgestrel, Ethinyl Estradiol Receives Approval in the U.S.
FDA
13 Feb 2023
Share Share
FDA Approves Medicines360`s LILETTA to Prevent Pregnancy for up to Eight Years

FDA Approves Medicines360`s LILETTA to Prevent Pregnancy for up to Eight Years
PRNEWSWIRE
14 Nov 2022
Share Share
Bayer get EU nod for extended use of contraceptive Mirena

Bayer get EU nod for extended use of contraceptive Mirena
PHARMAPHORUM
14 Oct 2022
Share Share